By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

Let's focus on what we can do, not what we can't!

Online Platform By Disabled People for Disabled People

  • Home
  • >
  • Latest Headlines
  • >
  • LSU Health New Orleans Develops New Human Cell Line to Study Blinding Eye Disorders – LSU Health Sciences Center

LSU Health New Orleans Develops New Human Cell Line to Study Blinding Eye Disorders – LSU Health Sciences Center

Friday, 15 July, 2022

LSU Health New Orleans Develops New Human Cell Line to Study Blinding Eye Disorders – LSU Health Sciences Center


Under the direction of Boyd Professor Nicolas Bazan, MD, PhD, scientists at LSU Health New Orleans Neuroscience Center of Excellence have developed a new, experimental human cell line from retinal pigment epithelial cells. Called ABC, these cells so closely resemble and retain the properties of native retinal pigment epithelial (RPE) cells, the research team has shown that they are a reliable cell system to study retinal degenerative diseases. Their findings are published in Frontiers in Neuroscience, available online here.
Retinal pigment epithelial (RPE) cells serve as part of a blood/retina barrier. They protect the integrity of photoreceptor cells critical to vision.
“Retinal pigment epithelial cells and photoreceptor cells are at constant risk for uncompensated oxidative stress because of their oxygen-rich environment, high flux of polyunsaturated fatty acids and high metabolic activity,” notes Dr. Bazan. “Impairments in RPE cell protection may lead to retinal degenerative diseases, including age-related macular degeneration (AMD).”
Read more at: https://www.lsuhsc.edu/newsroom/LSU%20Health%20New%20Orleans%20Develops%20New%20Human%20Cell%20Line%20to%20Study%20Blinding%20Eye%20Disorders.html

Categories :
  • Latest Headlines
  • Visual Impairment
Socials :

Recent posts

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Ability Today to your inbox.

By clicking “submit,” you agree to receive emails from Ability Today and accept our web terms of use and privacy and cookie policy.

Our Awards and Partners

Copyright © 2022 All rights reserved